Excised melanocytic lesions in children and adolescents - A 10-year survey

British Journal of Dermatology

Volumn 167, Issue 2, 2012, Pages 368-373

  Moscarella, E ^a   Zalaudek, I ^b   Cerroni, L ^b   Sperduti, I ^c   Catricala C ^a   Smolle, J ^b   Hofmann Wellenhof, R ^b   Sgambato, A ^d   Pellacani, G ^e   Argenziano, G ^f  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f Dermatology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADOLESCENT DISEASE; ADULT; CANCER DIAGNOSIS; CHILD; CHILDHOOD CANCER; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; NEVUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SCHOOL CHILD; SKIN BIOPSY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; HUMANS; INFANT; MELANOMA; NEVUS, PIGMENTED; NUMBERS NEEDED TO TREAT; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84864400983     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10952.x     Document Type: Review

References (25)

1. Baade PD, Youl PH, Janda M, et al. Factors associated with the number of lesions excised for each skin cancer: a study of primary care physicians in Queensland, Australia. Arch Dermatol 2008; 144: 1468-76.
2. English DR, Del Mar C, Burton RC,. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust 2004; 180: 16-19.
3. Hansen C, Wilkinson D, Hansen M, Argenziano G,. How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia. J Am Acad Dermatol 2009; 61: 599-604.
4. National Cancer Institute. Seer Cancer Statistics Review 1975-2007. Available at: (last accessed 26 April 2012).
5. Richtig E, Berghold A, Schwantzer G, et al. Clinical epidemiology of invasive cutaneous malignant melanoma in the Austrian province Styria in the years 2001-2003 and its relationship with local geographical, meteorological and economic data. Dermatology 2007; 214: 246-52.
6. Ahmad O, Boschi-Pinto C, Lopez AD, et al. Age Standardization of Rates: a new WHO standard. Geneva: World Health Organization, 2001.
7. Strouse JJ, Fears TR, Tucker MA, Wayne AS,. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005; 23: 4735-41.
8. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 2005; 115: 649-54.
9. Karlsson P, Boeryd B, Sander B, et al. Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92. Acta Derm Venereol 1998; 78: 289-92.
10. Huynh PM, Grant-Kels JM, Grin CM,. Childhood melanoma: update and treatment. Int J Dermatol 2005; 44: 715-23.
11. Lewis KG,. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg 2004; 34: 152-9.
12. Schaffer JV,. Pigmented lesions in children: when to worry. Curr Opin Pediatr 2007; 19: 430-40.
13. Bonifazi E, Bilancia M, Berloco A, et al. Malignant melanoma in children aged 0-12. Review of 289 cases of the literature. Eur J Pediatr Dermatol 2001; 11: 157-75.
14. Krengel S, Haushild A, Schafer T,. Melanoma risk in congenital melanocytic naevi: a systematic review. Br J Dermatol 2006; 155: 1-8.
15. Marghoob AA, Borrego JP, Halpern AC,. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002; 20: 607-16.
16. Price HN, Schaffer JV,. Congenital melanocytic nevi-when to worry and how to treat: facts and controversies. Clin Dermatol 2010; 28: 293-302.
17. Brunetti B, Nino M, Sammarco E, Scalvenzi M,. Spitz naevus: a proposal for management. J Eur Acad Dermatol Venereol 2005; 19: 391-3.
18. Ferrara G, Argenziano G, Soyer HP, et al. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 2005; 141: 1381-7.
19. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumor: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999; 30: 513-20.
20. Peris K, Ferrari A, Argenziano G, et al. Dermoscopic classification of Spitz/Reed nevi. Clin Dermatol 2002; 20: 259-62.
21. Kittler H, Pehamberger H, Wolff K, Binder M,. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol 2000; 43: 467-76.
22. Kittler H, Seltenheim M, Dawid M, et al. Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol 2000; 136: 316-20.
23. Pizzichetta MA, Massone C, Grandi G, et al. Morphologic changes of acquired melanocytic nevi with eccentric foci of hyperpigmentation ('Bolognia sign') assessed by dermoscopy. Arch Dermatol 2006; 142: 479-83.
24. Menzies SW, Stevenson ML, Altamura D, Byth K,. Variables predicting change in benign melanocytic nevi undergoing short-term dermoscopic imaging. Arch Dermatol 2011; 147: 655-9.
25. Scope A, Dusza SW, Marghoob AA, et al. Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system. J Invest Dermatol 2011; 131: 1615-21.